E
23.43
0.34 (1.47%)
| 前收盘价格 | 23.09 |
| 收盘价格 | 23.20 |
| 成交量 | 3,004,630 |
| 平均成交量 (3个月) | 6,993,890 |
| 市值 | 11,641,511,936 |
| 市盈率 (P/E TTM) | 334.71 |
| 预期市盈率 (P/E Forward) | 20.53 |
| 价格/销量 (P/S) | 2.28 |
| 股市价格/股市净资产 (P/B) | 1.50 |
| 52周波幅 | |
| 利润日期 | 5 Nov 2025 |
| 营业毛利率 | 8.43% |
| 营业利益率 (TTM) | 10.14% |
| 稀释每股收益 (EPS TTM) | 0.750 |
| 季度收入增长率 (YOY) | -1.00% |
| 季度盈利增长率 (YOY) | 109.40% |
| 总债务/股东权益 (D/E MRQ) | 69.18% |
| 流动比率 (MRQ) | 2.71 |
| 营业现金流 (OCF TTM) | 535.00 M |
| 杠杆自由现金流 (LFCF TTM) | 1.32 B |
| 资产报酬率 (ROA TTM) | 1.14% |
| 股东权益报酬率 (ROE TTM) | 6.01% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Drug Manufacturers - Specialty & Generic (US) | 混合的 | 混合的 |
| Drug Manufacturers - Specialty & Generic (全球的) | 混合的 | 混合的 | |
| 股票 | Elanco Animal Health Incorporat | 看涨 | 看涨 |
AIStockmoo 评分
-0.5
| 分析师共识 | 3.0 |
| 内部交易活动 | 2.0 |
| 价格波动 | -4.5 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | -0.5 |
| 平均 | -0.50 |
|
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production. |
|
| 部门 | Healthcare |
| 行业 | Drug Manufacturers - Specialty & Generic |
| 投资方式 | Small Core |
| 内部持股比例 | 1.03% |
| 机构持股比例 | 101.48% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 30.00 (Leerink Partners, 28.04%) | 购买 |
| 30.00 (Piper Sandler, 28.04%) | 购买 | |
| 中 | 29.00 (23.77%) | |
| 低 | 24.00 (Morgan Stanley, 2.43%) | 保留 |
| 平均值 | 28.20 (20.36%) | |
| 总计 | 4 购买, 1 保留 | |
| 平均价格@调整类型 | 26.03 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Keybanc | 25 Feb 2026 | 29.00 (23.77%) | 购买 | 26.84 |
| Morgan Stanley | 25 Feb 2026 | 24.00 (2.43%) | 保留 | 26.84 |
| 18 Dec 2025 | 22.00 (-6.10%) | 保留 | 22.09 | |
| Leerink Partners | 24 Feb 2026 | 30.00 (28.04%) | 购买 | 26.38 |
| JP Morgan | 19 Feb 2026 | 28.00 (19.50%) | 购买 | 25.20 |
| Piper Sandler | 22 Jan 2026 | 30.00 (28.04%) | 购买 | 24.91 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合